🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Research also found communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.

Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to potentially significant medical dangers”.